Simvastatin and clarithromycin — GPhC CRA MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: D — Clarithromycin increases simvastatin exposure and myopathy risk
Clarithromycin strongly inhibits CYP3A4 and can increase simvastatin levels, increasing risk of myopathy and rhabdomyolysis. The prescriber should be contacted to withhold simvastatin temporarily or choose an alternative antibiotic where appropriate. Existing muscle aches make counselling and safety-netting important. The interaction is not loss of statin effect.
Reference: BNF Simvastatin interactions; BNF Clarithromycin